Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein

Melanoma Research

Volumn 9, Issue 1, 1999, Pages 69-73

  Kageshita, T ^a   Matsui, T ^a   Hirai, S ^a   Fukuda, Y ^a   Ono, T ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced melanoma; Hypercalcaemia; Parathyroid hormone related protein (PTH rP)

Indexed keywords

CALCIUM; PARATHYROID HORMONE RELATED PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCALCEMIA; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0032903739     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199902000-00009     Document Type: Article

References (24)

1. 1. Muggia FM, Heinemann HO. Hypercalcemia associated with neoplastic disease. Ann Intern Med 1970; 73: 281-290.
2. 2. Broadus AE, Mangin M, Ikeda K, et al. Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. N Engl J Med 1988; 319: 556-563.
3. 3. Burtis WJ, Brady TG, Orloff JJ, et al. Immunochemical characterisation of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990; 322: 1106-1112.
4. 4. Suva LJ, Winslow GA, Wettenhall REH, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237: 893-896.
5. 5. Body JJ, Dumon JC, Thirion M, et al. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy. J Bone Mineral Res 1993; 8: 701-706.
6. 6. Henderson JE, Shustik C, Kremer R, et al. Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J Bone Mineral Res 1990; 5: 105-113.
7. 7. Budayr AA, Nissenson RA, Klein RF, et al. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989; 111: 807-812.
8. 8. Kao PC, Klee GG, Taylor RL, et al. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions. Mayo Clin Proc 1990; 65: 1399-1407.
9. 9. Grill V, Ho P, Body JJ, et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991; 73: 1309-1315
10. 10. Magner RF, Sklarek HM, Kulkarni GA, et al. Pulmonary carcinoid associated with a parathormone producing melanoma. J Dermatol Surg Oncol 1983; 9: 562-566.
11. 11. Elias AN, Pandian MR, Jacowatz J. Parathyroid hormone-related protein in patients with malignant melanoma. Arch Dermatol 1992; 128: 278-279.
12. 12. Payne RB, Little AJ, Williams RB, et al. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ 1973; iv: 643-646.
13. 13. Beahrs OH, Henson DE, Hutter RVP, et al. (eds) Malignant melanoma of the skin. In: Manual for Staging of Cancer: American Joint Committee on Cancer, 4th edn. Philadelphia: JB Lippincott, 1992: 143-148.
14. 14. Burt ME, Brennan MF. Hypercalcemia and malignant melanoma. Am J Surg 1979; 137: 790-794.
15. 15. Levy I, Feun L. Hypercalcemia and malignant melanoma. Am J Clin Oncol 1990; 13: 524-526.
16. 16. Wagner RF Jr, Nathanson L. Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma. J Am Acad Dermatol 1986; 14: 249-256.
17. 17. Borden H, Hummer GJ, Landon CW, et al. The use of procaine in acquired malignant hyperthermia in a patient with malignant melanoma metastatic to the parathyroid gland. A case report. Can Anaesth Soc J 1976; 23: 616-623.
18. 18. Danks JA, Ebeling PR, Hayman J, et al. Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Mineral Res 1989; 4: 273-278.
19. 19. Legha SS, Powell K, Buzder AU, et al. Tamoxifen-induced hypercalcemia in breast cancer. Cancer 1981; 47: 2803-2806.
20. 20. Demers LM, Allegra JC, Harvey HA, et al. Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer 1977; 39; 1559-1562.
21. 21. Honda S, Yamaguchi K, Miyake Y, et al. Production of parathyroid hormone-related protein in adult T-cell leukemia cells. Jpn J Cancer Res 1988; 79: 1264-1268.
22. 22. Hayman JA, Danks JA, Ebeling PR, et al. Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages. J Pathol 1989; 158: 293-296.
23. 23. Atillasoy EJ, Burlis WJ, Milstone LM. Immunohistochemical localization of parathyroid hormone-related proprotein (PTHRP) in normal human skin. J Invest Dermatol 1991; 96: 277-280.
24. 24. Aklilu F, Park M, Goltzman D, et al. Induction of parathyroid hormone-related peptide by the Ras oncogenes: role of Ras Farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy. Cancer Res 1997; 57: 4517-4522.